Company's Latest Solution Integrates Protocol Design, Document Generation, and Statistical Programming to Accelerate Trial Execution and Deliver Submission-ready Data "AI Conductor transforms clinical ...

LOS GATOS, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (ARDS) today announced positive feedback from the European Medicines Agency (EMA) on the Company’s proposed single ...

Clinical research has always been the backbone of medical progress, providing the data and insights needed to develop new treatments, improve patient outcomes, and advance public health. Yet, the ...

“We are particularly gratified to reach concurrence with the FDA on the overall study design, endpoints, and patient populations,” said Aridis CEO Vu Truong. “This provides a clear clinical and ...

New collaboration integrates Citeline's comprehensive trial databases with Evinova's AI-native Study Designer to optimize decisions to improve study outcomes BAAR, Switzerland & NEW YORK, February 26, ...

BRANFORD, Conn.--(BUSINESS WIRE)--Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced ...

LOS GATOS, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced positive feedback from the European Medicines Agency (EMA) on the Company’s proposed ...

New collaboration integrates Citeline's comprehensive trial databases with Evinova's AI-native Study Designer to optimize decisions to improve study outcomes Evinova, a global health tech company with ...

Diffuse cutaneous systemic sclerosis (“dcSSc”) is a rare, progressive autoimmune disease characterized by immune activation, vasculopathy and fibrosis affecting the skin and internal organs, including ...